InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Dasu Badri N, Directeur de l'Ingénierie. Director active across 2 companies, notably Acelrx Pharmaceuticals INC. Aggregated, 15 filings have been recorded. History available since 6 February 2022. The latest transaction was filed on 2 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dasu Badri N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
2,444 shares@ US$0.722330.1% of flowCommon StockSEC:0001310803-26-000003:0
781 shares@ US$0.83619.8% of flowCommon StockSEC:0001310803-26-000002:0
15,000 shares0Common StockSEC:0001415889-25-009953:0
2,644 shares@ US$0.6747.8% of flowCommon StockSEC:0001415889-25-004443:0
879 shares@ US$0.629915.1% of flowCommon StockSEC:0001415889-25-003724:0
406 shares@ US$1.3013.8% of flowCommon StockSEC:0001209191-24-004246:0
14,667 shares0Common StockSEC:0001209191-24-004044:0
809 shares@ US$1.1023.3% of flowCommon StockSEC:0001209191-24-003308:0
398 shares@ US$1.315.0% of flowCommon StockSEC:0001209191-23-016330:0
776 shares@ US$1.6812.4% of flowCommon StockSEC:0001209191-23-009127:1
4,875 shares0Common StockSEC:0001209191-23-009127:0
458 shares@ US$2.028.8% of flowCommon StockSEC:0001209191-23-007818:0
5,612 shares@ US$0.406828.5% of flowCommon StockSEC:0001209191-22-016248:0
97,500 shares0Common StockSEC:0001209191-22-009349:0
6,830 shares@ US$0.431235.7% of flowCommon StockSEC:0001209191-22-007634:0
15 of 15 declarations
About Dasu Badri N
Badri N. Dasu is the Chief Engineering Officer at AcelRx Pharmaceuticals Inc. He oversees engineering and product development initiatives within the company. With expertise in the pharmaceutical sector, he plays a key role in innovation and enhancing the solutions offered by the company.
